RSS

CAR-T therapies

The London Clinic has announced it is the latest private hospital in the UK to offer CAR-T cell therapy to adult patients with diffuse large B-cell lymphoma – an aggressive form of blood cancer. Read more

News

NHS England has announced a landmark deal, giving children and young people access to Novartis’ Kymriah (a chimeric antigen receptor T-cell, CAR-T, therapy) — a personalised therapy for the treatment of cancer. Read more

News

A Master Service Agreement has been entered by TxCell and Lonza Pharma & Biotech for the manufacture of a CAR-Treg cellular product (TX200), which is in development for the prevention of chronic rejection after organ transplantation. Read more

News

Swiss-based healthcare company, Novartis, has revealed that the US Food and Drug Administration (FDA) has approved its CAR-T therapy, Kymriah, for its second distinct indication. Read more

News

Data and analytics company, GlobalData, has released its findings from its review of the biopharmaceutical industry from 2017. Read more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

In this article, Frances Salisbury (partner) and Adam Gregory (associate) — European Patent Attorneys in the Life Sciences team at Mewburn Ellis — discuss innovation and IP of CAR-T therapies in more detail. Read more

, Opinion